Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors

Figure 1

Flowchart of patient selection. Group A for overall survival and distant metastases-free survival and Group B for disease-free survival were developed based on the eligibility criteria for two KROG studies and SNU/AMC study, respectively.